Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II)

BACKGROUND: The World Health Organization recommends annual mass azithromycin administration in communities with at least 10% prevalence of trachomatous inflammation–follicular (TF) in children, with further treatment depending on reassessment after 3–5 years. However, the effect of stopping mass az...

Descripción completa

Detalles Bibliográficos
Autores principales: Keenan, Jeremy D., Tadesse, Zerihun, Gebresillasie, Sintayehu, Shiferaw, Ayalew, Zerihun, Mulat, Emerson, Paul M., Callahan, Kelly, Cotter, Sun Y., Stoller, Nicole E., Porco, Travis C., Oldenburg, Catherine E., Lietman, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091918/
https://www.ncbi.nlm.nih.gov/pubmed/30106956
http://dx.doi.org/10.1371/journal.pmed.1002633